Description
Trenbolone AQ 50 by PharmaQo is a pharmaceutical-grade injectable containing 50 mg/mL Trenbolone Acetate in aqueous suspension, a fast-acting anabolic compound researched for its effects on tissue repair, nitrogen retention, and muscle-wasting conditions in controlled scientific settings.
The acetate ester offers rapid onset and clearance, making it suitable for short-term research protocols requiring frequent administration.
Product Details:
Active Ingredient:
-
Trenbolone Acetate
Concentration: 50 mg/mL
Form: Injectable aqueous suspension (intramuscular)
Vial Size: 10 mL multidose vial
Pharmacokinetics:
Trenbolone Acetate has a half-life of approximately 1–3 days, requiring administration every 1–2 days in research settings.
Usage Recommendations:
-
Indications (Research Context): Investigational use in anabolic research, tissue repair, nitrogen balance (not for human use)
-
Typical Dosage (Research Use): 50–100 mg every 1–2 days, depending on research design
-
Monitoring: Liver function, lipid profile, androgenic markers, cardiovascular effects
-
Cycle/Duration: Typically short-term protocols, depending on study needs
Disclaimer:
This product is intended strictly for research and educational purposes. It is not approved for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with contraindications. Always follow local research laws and ethical guidelines.